FDA applicant
Stryker Neurovascular
FDA records 36 decisions for Stryker Neurovascular (Fremont, CA) from 2011 to 2026: 34 510(k) clearances and 2 original PMA approvals. Most are in product codes HCG (Device, Neurovascular Embolization) and QJP (Catheter, Percutaneous, Neurovasculature). Since 2016 its 510(k)s took a median of 114 days from receipt to decision, against 111 for FDA’s reviews in the same codes and years. Its devices cite 44 predicates, 20 of them its own earlier devices. 46 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Stryker Neurovascular’s devices, and how often a recall has named them.
FDA decisions per year
4in 2025
2026 so far, outlined.
Recalls per year
1in 2026
Class I Class II/III not classified
Planning a device like Stryker Neurovascular’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Stryker”
FDA records each applicant name separately; these may or may not be the same firm.